Biosimilars Insights

Size opportunities and threats in this lucrative market

Speak to our team

Size the opportunity in this emerging space and evaluate the disruptive effects of biosimilars

Assess the market size for biosimilars, optimize your market access strategy and determine how to best position your brand with comprehensive intelligence spanning regulatory pathways, payer policies, current treatment dynamics and competitive intelligence.


  • Leverage therapy area insights
    Assess the current and future market size for biosimilars across six leading therapy areas: oncology, immunology, endocrinology, nephrology, respiratory, and ophthalmology.
  • Keep track of emerging biosimilars
    Evaluate the global biosimilars pipeline and launch timing in major markets.
  • Optimize your market access strategy
    Track how payers and physicians respond to launches of biosimilars and understand the factors that will drive or limit use.
  • Inform strategic decision-making
    Use actionable recommendations based on strategies used by both reference brand and biosimilar developers to defend and maximize their market share.


  • Coverage of the biosimilars market since 2006
  • Market sizing for over 30 reference brand biologics
  • 10-year interactive forecast covering the U.S., Europe and Japan
  • Annual surveys of over 500 physicians across six key specialties and in-depth interviews with payers from the U.S. and E.U.

Related products



Get started

Talk to us about your strategic portfolio planning challenges.

Speak to our team